PolyMedix, a company that is developing drugs made by a proprietary computational drug design system to mimic natural germ-killing proteins found in humans.
Its goal is to map the complex network of signalling reactions which cells use as an internal messaging system, and then feed this information into other computational models.
The solution: More computational horsepower to speed up response times, and features designed to reassure the driver that the system knows a button was pushed.